The AGAAAAGA Palindrome in PrP Is Required to Generate a Productive PrPSc-PrPC Complex That Leads to Prion Propagation*
暂无分享,去创建一个
[1] J. Collinge,et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease , 2003, Nature.
[2] S. Lindquist,et al. Conversion of PrP to a Self-Perpetuating PrPSc-like Conformation in the Cytosol , 2002, Science.
[3] David A Agard,et al. Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] Pauline M. Rudd,et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity , 2001, Nature.
[5] A. Kenworthy,et al. Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. , 2001, Methods.
[6] S. Hell,et al. KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET. , 2001, Developmental cell.
[7] J. Lippincott-Schwartz,et al. Studying protein dynamics in living cells , 2001, Nature Reviews Molecular Cell Biology.
[8] B. Caughey,et al. Inhibition of Interactions and Interconversions of Prion Protein Isoforms by Peptide Fragments from the C-terminal Folded Domain* , 2001, The Journal of Biological Chemistry.
[9] B. Caughey,et al. Interactions between prion protein isoforms: the kiss of death? , 2001, Trends in biochemical sciences.
[10] F. Cohen,et al. Dominant-Negative Inhibition of Prion Formation Diminished by Deletion Mutagenesis of the Prion Protein , 2000, Journal of Virology.
[11] R. Tsien,et al. Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] Fran Maher,et al. The Hydrophobic Core Sequence Modulates the Neurotoxic and Secondary Structure Properties of the Prion Peptide 106‐126 , 1999, Journal of neurochemistry.
[13] S. Lindquist,et al. De novo generation of a PrPSc-like conformation in living cells , 1999, Nature Cell Biology.
[14] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[15] B. Chesebro,et al. Specific Inhibition of in Vitro Formation of Protease-resistant Prion Protein by Synthetic Peptides* , 1998, The Journal of Biological Chemistry.
[16] A. Bürkle,et al. Overexpression of Nonconvertible PrPcΔ114–121 in Scrapie-Infected Mouse Neuroblastoma Cells Leads to trans-Dominant Inhibition of Wild-Type PrPSc Accumulation , 1998, Journal of Virology.
[17] F E Cohen,et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.
[18] F. Cohen,et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] F. Cohen,et al. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Cohen,et al. Recombinant scrapie-like prion protein of 106 amino acids is soluble. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[22] H. Kretzschmar,et al. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment , 1994, Neuroreport.
[23] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Forloni,et al. Neurotoxicity of a prion protein fragment , 1993, Nature.
[25] F. Cohen,et al. Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Prusiner,et al. Chimeric prion protein expression in cultured cells and transgenic mice , 1992, Protein science : a publication of the Protein Society.
[27] G. J. Raymond,et al. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state , 1991, Journal of virology.
[28] S. Prusiner,et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins , 1988, Journal of virology.
[29] J. Mastrianni. Prion diseases , 2020, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease.